[Hyposensitizing and antioxidative pharmacotherapy of the cyst-like structures in the maxillary sinuses].
G A
GA
Gadzhimirzaev
M A
MA
Shakhnazarov
R G
RG
Gadzhimirzaeva
S N
SN
Abdulaeva
D000293:Adolescent; D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D002090:Butyrophenones / Q000008:administration & dosage / Q000494:pharmacology; D003560:Cysts / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008443:Maxillary Sinus / Q000187:drug effects / Q000473:pathology*; D015523:Maxillary Sinusitis / Q000188:drug therapy*; D008875:Middle Aged; D010847:Picolines / Q000008:administration & dosage / Q000494:pharmacology; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology; D065631:Rhinitis, Allergic / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
D000975:Antioxidants; D002090:Butyrophenones; D006634:Histamine H1 Antagonists; D010847:Picolines; D010880:Piperidines; C070020:emoxypine succinate; C058249:ebastine